Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Chemomab Therapeutics Ltd ADR (NQ: CMMB )

1.380 -0.040 (-2.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemomab Therapeutics Ltd ADR

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
Via Benzinga
Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY
Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY 
Via Benzinga
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Cosmos Holdings (NASDAQ:COSM) shares increased by 27.9% to $0.15 during Friday's pre-market session. The market value of their outstanding shares is at $12.3 million. 
Via Benzinga
Earnings Scheduled For November 11, 2022
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is expected to report quarterly loss at $0.37 per share on revenue of $919.90 million. 
Via Benzinga
Earnings Preview: Chemomab Therapeutics
Chemomab Therapeutics (NASDAQ:CMMB) is set to give its latest quarterly earnings report on Friday, 2022-11-11. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Chemomab Therapeutics: Q2 Earnings Insights
  Chemomab Therapeutics (NASDAQ:CMMB) reported its Q2 earnings results on Friday, August 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For August 12, 2022
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million. 
Via Benzinga
Earnings Outlook For Chemomab Therapeutics
  Chemomab Therapeutics (NASDAQ:CMMB) is set to give its latest quarterly earnings report on Friday, 2022-08-12. Here's what investors need to know before the announcement. 
Via Benzinga
79 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Chemomab Therapeutics: Q1 Earnings Insights
Chemomab Therapeutics (NASDAQ:CMMB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Chemomab Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
Chemomab Therapeutics (NASDAQ:CMMB) will host a conference call at 08:00 AM ET on May 12, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Innate Pharma (NASDAQ:IPHA) stock increased by 13.7% to $3.32 during Thursday's pre-market session. The market value of their outstanding shares is at $264.6... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV... 
Via Benzinga
Earnings Scheduled For March 9, 2022
Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million. • Express (... 
Via Benzinga
55 Biggest Movers From Yesterday
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) gained 44.8... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Eloxx Pharmaceuticals (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Applied DNA Sciences (NASDAQ:APDN... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
Upgrades For CarMax Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Adicet Bio (NASDAQ:ACET) stock increased by 37.85% to $13.51 during Monday's pre-market session. The market value of their outstanding shares is at $431.7... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Celyad Oncology (NASDAQ:CYAD) shares rose 22.75% to $4.37 during Friday's pre-market session. The company's market cap stands at $70.3 million. Biolase (... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Omeros (NASDAQ:OMER) stock increased by 15.68% to $7.89 during Thursday's pre-market session. The market value of their outstanding shares is at $493.4 million... 
Via Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-... 
Via Benzinga
Exposures COVID-19
FDA Signs Off Chemomab's Lead Candidate Mid-Stage Study In Bile Duct Disease
The FDA has cleared Chemomab Therapeutics Ltd's (NASDAQ: CMMB) Investigational New Drug (IND) application for CM-101 for the rare disease primary sclerosing... 
Via Benzinga
Exposures Product Safety
54 Biggest Movers From Yesterday
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an announcement the company will merge with Trump Media... 
Via Benzinga
Topics Government
Exposures Political
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.